Files
2026-07-06 17:27:20 -04:00

8.3 KiB
Raw Permalink Blame History

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
type title description jurisdiction legislature session identifier citation classification subjects status primary_sponsors version_count action_count vote_count first_action last_action source source_identifier source_url source_hash vintage source_snapshot retrieved_at confidence tags
Bill Prescription drug rebates and pricing. Requires a pharmacy benefit manager to provide a report to the department of insurance at least every six months. Provides that the report must include the: (1) overall aggregate amount charged to a health plan for all pharmaceutical claims processed by the pharmacy benefit manager; and (2) overall aggregate amount paid to pharmacies for claims processed by the pharmacy benefit manager. Requires that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty. us/states/in Indiana General Assembly 2023 SB 8 Indiana SB 8 (2023)
bill
HEALTH
Health Care Costs; Health Insurance
HEALTH
Health Care Reform
enacted
Donna Schaibley
Ed Charbonneau
Mike Bohacek
Vaneta Becker
6 42 1 2023-01-09 2023-05-04 openstates ocd-bill/89871f11-3d5a-4b95-ad2d-86d752a9e5ac http://iga.in.gov/legislative/2023/bills/senate/8 cadd04387a24cddffdb67f64d176ab47d6bc8841a943ee85f09cd94eb1adb762 2026-07-01 https://data.openstates.org/daily/2026-07-01/public.pgdump 2026-07-06 reported
legislation
bill
us-in

Indiana SB 8 (2023) — Prescription drug rebates and pricing.

Requires a pharmacy benefit manager to provide a report to the department of insurance at least every six months. Provides that the report must include the: (1) overall aggregate amount charged to a health plan for all pharmaceutical claims processed by the pharmacy benefit manager; and (2) overall aggregate amount paid to pharmacies for claims processed by the pharmacy benefit manager. Requires that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

  1. Engrossed Senate Bill (H) (committee substitute) — source
  2. Engrossed Senate Bill (S) (committee substitute) — source
  3. Enrolled Senate Bill (S) (committee substitute) — source
  4. Introduced Senate Bill (S) (committee substitute) — source
  5. Senate Bill (H) (committee substitute) — source
  6. Senate Bill (S) (committee substitute) — source

Votes

  • SB 8 - Charbonneau - 3rd Reading — 425 (pass) · upper

Sponsors

  • Donna Schaibley — primary (person)
  • Ed Charbonneau — primary (person)
  • Mike Bohacek — primary (person)
  • Vaneta Becker — primary (person)
  • Brad Barrett — cosponsor (person)
  • Gregory Porter — cosponsor (person)
  • Julie Olthoff — cosponsor (person)
  • Justin Busch — coauthor (person)
  • Lonnie Randolph — coauthor (person)
  • Michael Crider — coauthor (person)
  • Stacey Donato — coauthor (person)

Timeline

The legislative action history — every referral, reading, and vote.

  • 2023-01-09 Authored by Senator Charbonneau
  • 2023-01-09 First reading: referred to Committee on Health and Provider Services reading-1, referral-committee
  • 2023-01-30 Senator Bohacek added as second author
  • 2023-01-30 Senator Becker added as third author
  • 2023-02-13 Senator Busch added as coauthor
  • 2023-02-14 Senators Donato and Johnson added as coauthors
  • 2023-02-16 Committee report: do pass, adopted committee-passage
  • 2023-02-16 Senator Crider added as coauthor
  • 2023-02-20 Amendment #1 (Charbonneau) prevailed; voice vote amendment-passage
  • 2023-02-20 Second reading: amended, ordered engrossed reading-2
  • 2023-02-21 Senator Randolph added as coauthor
  • 2023-02-23 Third reading: passed; Roll Call 153: yeas 42, nays 5 passage, reading-3, reading-3
  • 2023-02-23 House sponsor: Representative Schaibley
  • 2023-02-23 Cosponsor: Representative Barrett
  • 2023-02-24 Referred to the House referral
  • 2023-02-28 First reading: referred to Committee on Insurance reading-1, referral-committee
  • 2023-03-13 Representative Olthoff added as cosponsor
  • 2023-04-06 Committee report: amend do pass, adopted committee-passage
  • 2023-04-11 Amendment #1 (Schaibley) prevailed; voice vote amendment-passage
  • 2023-04-11 Representative Porter added as cosponsor
  • 2023-04-11 Second reading: amended, ordered engrossed reading-2
  • 2023-04-12 Third reading: passed; Roll Call 406: yeas 94, nays 0 passage, reading-3, reading-3
  • 2023-04-12 Returned to the Senate with amendments receipt
  • 2023-04-13 Motion to dissent filed filing
  • 2023-04-13 Senate dissented from House amendments
  • 2023-04-18 House conferees appointed: Carbaugh and Shackleford
  • 2023-04-18 House advisors appointed: Barrett, Lehman, Schaibley and Porter
  • 2023-04-19 Senate conferees appointed: Charbonneau and Breaux
  • 2023-04-19 Senate advisors appointed: Melton and Bohacek
  • 2023-04-27 Representative Schaibley removed as advisor
  • 2023-04-27 Representative Carbaugh removed as conferee
  • 2023-04-27 Representative Schaibley added as conferee
  • 2023-04-27 CCR # 1 filed in the Senate filing
  • 2023-04-27 CCR # 1 filed in the House filing
  • 2023-04-27 Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 550: yeas 72, nays 21
  • 2023-04-27 Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 525: yeas 40, nays 9
  • 2023-04-27 Senator Johnson removed as coauthor
  • 2023-04-28 Signed by the President Pro Tempore passage
  • 2023-04-28 Signed by the President of the Senate passage
  • 2023-05-01 Signed by the Speaker passage
  • 2023-05-04 Public Law 166 became-law
  • 2023-05-04 Signed by the Governor executive-signature

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/89871f11-3d5a-4b95-ad2d-86d752a9e5ac. Confidence: reported (aggregated from official Indiana legislature records).